Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Keenan TDL. Geographic atrophy in age-related macular degeneration: a tale of two stages. Ophthalmol Sci. 2023;3(3): 100306. https://doi.org/10.1016/j.xops.2023.100306.
2. Sivaprasad S, Tschosik EA, Guymer RH, Kapre A, Suñer IJ, Joussen AM, Lanzetta P, Ferrara D. Living with geographic atrophy: an ethnographic study. Ophthalmol Ther. 2019;8(1):115–24. https://doi.org/10.1007/s40123-019-0160-3.
3. Sarda SP, Heyes A, Bektas M, Thakur T, Chao W, Intorcia M, Wronski S, Jones DL. Humanistic and economic burden of geographic atrophy: a systematic literature review. Clin Ophthalmol (Auckland, NZ). 2021;15:4629–44. https://doi.org/10.2147/OPTH.S338253.
4. Dinah C, Hoad G, Amblard J-C, Lui B, Quéré S, Amoaku W. MOASIC Study: a clinical, humanistic and economic burden of illness study among patients with geographic atrophy (GA) and their caregivers in Europe. EURETINA Congress 2023 Amsterdam Abstracts; 2023.
5. Joszt L. FDA approves first treatment for geographic atrophy. AJMC. 2023. https://www.ajmc.com/view/fda-approves-first-treatment-for-geographic-atrophy. Accessed 13 June 2023.